World's Best Scientists 2026 revealed!
Hans-Hartmut Peter

Hans-Hartmut Peter

D-Index & Metrics

Immunology

D-Index
72
Citations
20403
World Ranking
2204
National Ranking
152

Hans-Hartmut Peter publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hans-Hartmut Peter sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 333 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hans-Hartmut Peter D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hans-Hartmut Peter sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hans-Hartmut Peter is affiliated with the University of Freiburg in Germany. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on immunological and clinical investigations.

Their work covers several subfields including Immunology, Rehabilitation, Radiology, Nuclear Medicine and Imaging, Hematology, and Genetics. The scientist's main topics of study address Immunodeficiency and Autoimmune Disorders, Musculoskeletal Disorders and Rehabilitation, Monoclonal and Polyclonal Antibodies Research, Platelet Disorders and Treatments, Diabetes and associated disorders, Immune Cell Function and Interaction, as well as Systemic Lupus Erythematosus Research.

Hans-Hartmut Peter has published papers in multiple scientific journals. Recent publications include:

  • Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations, 2020, Journal of Allergy and Clinical Immunology
  • Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency, 2020, The Journal of Allergy and Clinical Immunology In Practice
  • Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations, 2020, Lupus Science & Medicine
  • 32. Emeriti-Treffen in Düsseldorf vom 9. bis 12. September 2021, 2022, Zeitschrift für Rheumatologie
  • Mitteilungen der DGRh - Veranstaltungen der Rheumaakademie, 2021, Zeitschrift für Rheumatologie

Their frequent co-authors include Hans D. Ochs, Charlotte Cunningham-Rundles, Donald C. Vinh, Peter Kießling, and Bernhard Greve.

Hans-Hartmut Peter has contributed repeatedly to several publication venues with the highest number of papers appearing in Zeitschrift für Rheumatologie. Other frequent venues are the Journal of Allergy and Clinical Immunology, The Journal of Allergy and Clinical Immunology In Practice, and Lupus Science & Medicine.

Best Publications

  • The EUROclass trial: defining subgroups in common variable immunodeficiency

    Claudia Wehr;Teemu Kivioja;Christian Schmitt;Berne Ferry

  • Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

    J. H. Korn;Maureen D Mayes;M. Matucci Cerinic;M. Rainisio

  • Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency

    Bodo Grimbacher;Andreas Hutloff;Michael Schlesier;Erik Glocker

  • Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

    Klaus Warnatz;Axel Denz;Ruth Dräger;Moritz Braun

  • Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

    U Salzer;H M Chapel;A D B Webster;Q Pan-Hammarström

  • Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

    Stephanie Kruetzmann;M. Manuela Rosado;Holger Weber;Ulrich Germing

  • ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells.

    Lukas Bossaller;Jan Andreas Burger;Ruth Draeger;Bodo Grimbacher

  • B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans

    Klaus Warnatz;Ulrich Salzer;Marta Rizzi;Beate Fischer

  • Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells

    Mirzokhid Rakhmanov;Baerbel Keller;Sylvia Gutenberger;Christian Foerster

  • A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

    U. Veronesi;J. Adamus;C. Aubert;E. Bajetta

  • A new CD21low B cell population in the peripheral blood of patients with SLE.

    Claudia Wehr;Hermann Eibel;Madhan Masilamani;Harald Illges

  • Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

    M Binks;J. R. Passweg;D. Furst;P. Mcsweeney

  • Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency.

    Klaus Warnatz;Lukas Bossaller;Ulrich Salzer;Andrea Skrabl-Baumgartner

  • Autologous stem cell transplantation in the treatment of systemic sclerosis: Report from the EBMT/EULAR Registry

    D. Farge;J.R. Passweg;J.M. van Laar;Z. Marjanovic

  • A New Type of Perinuclear Anti-Neutrophil Cytoplasmic Antibody (p-ANCA) in Active Ulcerative Colitis but not in Crohn's Disease

    Jörg A. Rump;Jürgen Schölmerich;Volker Gross;Michael Roth

  • Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes.

    Ulrich Salzer;Chiara Bacchelli;Sylvie Buckridge;Qiang Pan-Hammarström

  • Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.

    U Blum;C Buitrago-Tellez;A Mundinger;T Krause

  • Autologous haematopoietic stem cell transplants for autoimmune disease - feasibility and transplant-related mortality

    A Tyndall;A Fassas;J Passweg;C Ruiz de Elvira

  • Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Human Brain Tumors

    Klaus Lampert;Uwe Machein;Márcia Regina Machein;Walter Conca

  • Expansion of CD19hiCD21lo/neg B Cells in Common Variable Immunodeficiency (CVID) Patients with Autoimmune Cytopenia

    Klaus Warnatz;Claudia Wehr;Ruth Dräger;Sigune Schmidt

  • Common variable immunodeficiency: an update.

    Ulrich Salzer;Klaus Warnatz;Hans Hartmut Peter

  • Relevance of biallelic vs monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes

    U S Salzer;C Bacchelli;S Buckridge;Q Pan-Hammar-Strom

Frequent Co-Authors

Klaus Warnatz
Klaus Warnatz University of Freiburg
Bodo Grimbacher
Bodo Grimbacher University of Freiburg
Ulrich Salzer
Ulrich Salzer University of Freiburg
Michael T. Nurmohamed
Michael T. Nurmohamed University of Amsterdam
Reinhold E. Schmidt
Reinhold E. Schmidt Hannover Medical School
Karel Pavelka
Karel Pavelka Charles University
Helen Chapel
Helen Chapel University of Oxford
Alessandro Plebani
Alessandro Plebani University of Brescia
Hermann Eibel
Hermann Eibel University Medical Center Freiburg
Wilhelm K. Aicher
Wilhelm K. Aicher University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and related healthcare fields, there are several online educational pathways to consider. Accelerated programs have made it easier and faster to enter nursing professions that complement immunology knowledge. For example, an accelerated nurse practitioner program enables students to quickly advance into roles where immunology plays a critical role in patient care.

Non-nurses looking to transition into healthcare can benefit from 12-month accelerated nursing programs online for non nurses. These programs efficiently prepare students for nursing careers, allowing them to apply immunology principles in real-world clinical settings.

There are also accelerated nursing programs designed to reduce the time and prerequisites required to earn a Bachelor of Science in Nursing (BSN). These programs often appeal to busy students or career changers eager to specialize in fields related to immunology.

For those just beginning their nursing journey, exploring easy lpn programs to get into can be a practical first step. Licensed Practical Nurse (LPN) roles provide foundational healthcare experience that supports future advanced study in immunology or related disciplines.

Best Scientists Citing Hans-Hartmut Peter

Trending Scientists

Recently Published Articles